Cuál es el precio por Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Precio por Reviva Pharmaceuticals Holdings, Inc. (RVPHW) es de$0.003

Cuál es la capitalización de mercado por Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Capitalización de mercado por Reviva Pharmaceuticals Holdings, Inc. (RVPHW) es $343.91K

Reviva Pharmaceuticals Holdings, Inc. (RVPHW) Acciones en Circulación

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.

Año	Acciones en circulación	Cambiar
Not enough data for the provided dates.

Año

Acciones en circulación

Cambiar

Not enough data for the provided dates.

Empresa	Acciones en circulación	Diferencia	País
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-	BE

Empresa

Acciones en circulación

Diferencia

País